BRA
CELG

Bender Robert & Associates’s Celgene Corp CELG Stock Holding History

Bender Robert & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-52,623
Closed -$4.96M – 52
2019
Q1 		$4.96M Sell
52,623
-15,455
-23% -$1.35M 2.43% 15
2018
Q4 		$4.36M Sell
68,078
-1,243
-2% -$91.8K 2.52% 17
2018
Q3 		$6.2M Sell
69,321
-1,751
-2% -$155K 2.82% 11
2018
Q2 		$2.65M Sell
71,072
-4,441
-6% -$369K 1.39% 24
2018
Q1 		$6.74M Sell
75,513
-2,399
-3% -$230K 3.74% 9
2017
Q4 		$8.13M Sell
77,912
-1,466
-2% -$165K 4.51% 6
2017
Q3 		$11.6M Sell
79,378
-4,873
-6% -$664K 6.65% 3
2017
Q2 		$10.9M Sell
84,251
-244
-0.3% -$29.9K 6.71% 3
2017
Q1 		$10.5M Sell
84,495
-1,705
-2% -$204K 6.78% 2
2016
Q4 		$9.98M Sell
86,200
-2,676
-3% -$298K 7.07% 2
2016
Q3 		$9.29M Sell
88,876
-1,247
-1% -$135K 6.14% 4
2016
Q2 		$8.89M Sell
90,123
-2,011
-2% -$208K 6.27% 3
2016
Q1 		$9.22M Sell
92,134
-3,024
-3% -$311K 6.24% 4
2015
Q4 		$11.4M Sell
95,158
-1,262
-1% -$146K 7.3% 3
2015
Q3 		$10.4M Sell
96,420
-2,418
-2% -$300K 7.06% 3
2015
Q2 		$11.4M Sell
98,838
-2,173
-2% -$248K 6.79% 4
2015
Q1 		$11.6M Buy
101,011
+330
+0.3% +$39.4K 6.79% 3
2014
Q4 		$11.3M Sell
100,681
-599
-0.6% -$63.2K 7.37% 3
2014
Q3 		$9.6M Sell
101,280
-1,044
-1% -$94.2K 6.68% 4
2014
Q2 		$8.79M Sell
102,324
-1,366
-1% -$104K 6.22% 4
2014
Q1 		$7.24K Sell
103,690
-2,456
-2% -$194K 4.85% 6
2013
Q4 		$8.97M Sell
106,146
-952
-0.9% -$75.3K 6.74% 2
2013
Q3 		$8.25M Sell
107,098
-314
-0.3% -$22K 6.47% 2
2013
Q2 		$6.28M Buy
+107,412
New +$6.46M 5.39% 4

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bender Robert & Associates's CELG Position: Q2 2019 in Review

Bender Robert & Associates sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 52,623 shares — an estimated $4.96M sold.

Bender Robert & Associates first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $11.6M in Q1 2015. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Bender Robert & Associates reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Bender Robert & Associates sold 52,623 Celgene Corp shares in Q2 2019, an estimated $4.96M.
  • Bender Robert & Associates first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • Bender Robert & Associates's Celgene Corp position peaked at $11.6M in Q1 2015.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Bender Robert & Associates's 13F filing for Q2 2019, filed 30 Jul 2019.